General Court 22 June 2026, T-844/25 R (Biohaven Bioscience Ireland Ltd and Biohaven Therapeutics Ltd v European Medicines Agency.)
Also known as
European Union · · · Cited by 2 · 22-06-2026
ORDER OF THE PRESIDENT OF THE GENERAL COURT 22 June 2026 (*) ( Interim relief – Medicinal products for human use – Regulation (EC) No 726/2004 – Withdrawal of the application for marketing authorisation for Dazluma – Publication of the assessment report – Application for suspension of operation – Prima facie case – Urgency – Weighing up of interests ) In Case T‑844/25 R, Biohaven Bioscience
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (2 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit